SG Americas Securities’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

SG Americas Securities’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,540	Closed	-$296K	–	3352
2016 Q1	$296K	Sell	5,540 -5,520	-50%	-$407K	﹤0.01%	2003
2015 Q4	$1.25M	Buy	11,060 +7,450	+206%	+$821K	0.01%	997
2015 Q3	$425K	Buy	3,610 +1,525	+73%	+$199K	﹤0.01%	1117
2015 Q2	$161K	Sell	2,085 -6,900	-77%	-$452K	﹤0.01%	2084
2015 Q1	$520K	Buy	8,985 +3,218	+56%	+$137K	﹤0.01%	1435
2014 Q4	$186K	Buy	+5,767	New	+$173K	﹤0.01%	2475

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

SG Americas Securities's ANAC Position: Q2 2016 in Review

SG Americas Securities sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,540 shares — an estimated $296K sold.

SG Americas Securities first reported a position in ANAC in Q4 2014 and held it in 6 quarters. The position peaked at $1.25M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

SG Americas Securities reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
SG Americas Securities sold 5,540 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $296K.
SG Americas Securities first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 6 quarters.
SG Americas Securities's ANACOR PHARMACEUTICALS INC COM position peaked at $1.25M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on SG Americas Securities's 13F filing for Q2 2016, filed 3 Aug 2016.